Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Greg Lucier, Mingfu Zhu

Premium

NuVasive has appointed Greg Lucier to its board of directors. Lucier is chairman and CEO of Life Technologies, which was recently acquired by Thermo Fisher Scientific. Prior to Life Tech, Lucier held several senior management positions at General Electric, most recently as CEO and president of medical systems information technologies for GE Healthcare. He holds a BS in industrial engineering from Pennsylvania State University and an MBA from Harvard Graduate School of Business Administration.


Tute Genomics, which provides a cloud-based clinical genome interpretation pipeline, has appointed Mingfu Zhu as director of bioinformatics.

Zhu was previously an assistant professor at the Center for Human Genome Variation at Duke University Medical Center.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.